- News
Licensing
S&P 500 drug distributor Cardinal Health (CAH) easily topped fiscal fourth-quarter earnings forecasts despite a revenue shortfall. Shares of the S&P 500 drug distributor held in a buy zone. Rival McKesson (MCK), which whipsawed after its earnings report last week, has climbed back near a buy point. Cencora (COR), another big S&P 500 drug distributor, also is near a buy…
Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Related news
Cardinal Health Bolts Higher Despite Mixed Earnings. Here's Why.
8/11/2026 Cardinal Health stock jumped Tuesday after the medical wholesaler's fiscal 2027 guidance handily beat Wall Street's expectations.
8/11/2026 Cardinal Health stock jumped Tuesday after the medical wholesaler's fiscal...
Today's Spotlight
IBD Live Summer Sale
Watch experts identify winning stocks in real time—save $400+ on 6 months of IBD Live.Join MarketDiem for $20/Year
Simple, quick, actionable. Invest like a pro with IBD’s newsletter for $20/year!Join IBD’s Virtual Trading Summit
Want to learn strategies for picking top stocks? Join IBD’s free online workshop on 8/15.More News
-
Tokenization is coming to the stock market, promising increased liquidity, lower costs and immediate trade settlements as transactions move to public blockchains. (© Jon Krause)
Tokenization Promises To Break Trading Barriers. What Investors Need To Know. -
CPI Inflation Data Cools As Expected, May Keep Fed Rate Hikes On Hold (Live Coverage)
-
IBD 50 Stock Mines New Buy Zone. Mother Lode In Sight?
